Rapid Micro Biosystems Inc - Asset Resilience Ratio
Rapid Micro Biosystems Inc (RPID) has an Asset Resilience Ratio of 14.65% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Rapid Micro Biosystems Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Rapid Micro Biosystems Inc's Asset Resilience Ratio has changed over time. See how leveraged is Rapid Micro Biosystems Inc's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Rapid Micro Biosystems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Rapid Micro Biosystems Inc market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $9.13 Million | 14.65% |
| Total Liquid Assets | $9.13 Million | 14.65% |
Asset Resilience Insights
- Moderate Liquidity: Rapid Micro Biosystems Inc has 14.65% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Rapid Micro Biosystems Inc Industry Peers by Asset Resilience Ratio
Compare Rapid Micro Biosystems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 9.16% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
LIFETECH SCI.DL-00000125
F:81X |
Medical Devices | 8.59% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
Annual Asset Resilience Ratio for Rapid Micro Biosystems Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Rapid Micro Biosystems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 24.40% | $18.27 Million | $74.85 Million | -10.05pp |
| 2024-12-31 | 34.45% | $33.82 Million | $98.17 Million | -12.79pp |
| 2023-12-31 | 47.24% | $67.77 Million | $143.45 Million | +4.45pp |
| 2022-12-31 | 42.79% | $81.58 Million | $190.65 Million | +36.53pp |
| 2021-12-31 | 6.27% | $15.11 Million | $241.17 Million | -15.16pp |
| 2020-12-31 | 21.43% | $15.00 Million | $70.00 Million | +20.97pp |
| 2019-12-31 | 0.46% | $146.00K | $31.69 Million | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more